Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice

Mucosal Immunology

Volumn 10, Issue 1, 2017, Pages 104-116

  Yang, J Y ^a,b   Lee, Y S ^a   Kim, Y ^a   Lee, S H ^a   Ryu, S ^b   Fukuda, S ^c   Hase, K ^c   Yang, C S ^d   Lim, H S ^a   Kim, M S ^a   Kim, H M ^e   Ahn, S H ^f   Kwon, B E ^f   Ko, H J ^f   Kweon, M N ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c KEIO UNIVERSITY   (Japan)

^d Hanyang University   (South Korea)

^e Yonsei University Wonju   (South Korea)

^f Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SHORT CHAIN FATTY ACID; ATG7 PROTEIN, MOUSE; AUTOPHAGY RELATED PROTEIN 7;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BACTEROIDES; BACTEROIDES ACIDIFACIENS; BODY WEIGHT; COMMENSAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DENDRITIC CELL; EPITHELIUM CELL; FAT MASS; FECES LEVEL; FECES MICROFLORA; FEMALE; HOST; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MACROPHAGE; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PROTEIN EXPRESSION; PYROSEQUENCING; SEQUENCE ANALYSIS; SPECIES COMPOSITION; SPECIES DIVERSITY; SPECIES RICHNESS; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; FECES; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SYMBIOSIS; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANIMALS; AUTOPHAGY-RELATED PROTEIN 7; BACTEROIDES; CELLS, CULTURED; DIPEPTIDYL PEPTIDASE 4; FECES; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; INSULIN RESISTANCE; INTESTINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; PPAR ALPHA; SYMBIOSIS;

EID: 85011081956     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.42     Document Type: Article

References (49)

1. Kopelman, P.G. Obesity as a medical problem. Nature 404, 635-643 (2000).
2. Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H. &Cai, D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73 (2008).
3. Kuma, A. et al. The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036 (2004).
4. Levine, B., Mizushima, N. &Virgin, H.W. Autophagy in immunity and inflammation. Nature 469, 323-335 (2011).
5. Klionsky, D.J. The autophagy connection. Dev. Cell 19, 11-12 (2010).
6. Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131-1135 (2009).
7. Yang, L., Li, P., Fu, S., Calay, E.S. &Hotamisligil, G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11, 467-478 (2010).
8. Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517 (2009).
9. Kim, K.H. et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat. Med. 19, 83-92 (2013).
10. Delzenne, N.M., Neyrinck, A.M., Backhed, F. &Cani, P.D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7, 639-646 (2011).
11. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. &Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102, 11070-11075 (2005).
12. Ley, R.E., Turnbaugh, P.J., Klein, S. &Gordon, J.I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006).
13. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
14. Chikayama, E. et al. Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal. Chem. 82, 1653-1658 (2010).
15. Ridaura, V.K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
16. Backhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101, 15718-15723 (2004).
17. Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489 (2006).
18. Stepanov, V., Stankov, K. &Mikov, M. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J. Recept Signal Transduct Res. 33, 213-223 (2013).
19. Drucker, D.J. &Nauck, M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705 (2006).
20. Ahren, B. &Schmitz, O. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes. Horm. Metab. Res. 36, 867-876 (2004).
21. Katsuma, S., Hirasawa, A. &Tsujimoto, G. Bile acids promote glucagonlike peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 329, 386-390 (2005).
22. Sato, H. et al. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem. Biophys. Res. Commun. 362, 793-798 (2007).
23. Miyamoto, Y. &Itoh, K. Bacteroides acidifaciens sp. nov., isolated from the caecum of mice. Int. J. Syst. Evol. Microbiol. 50 (Pt 1), 145-148 (2000).
24. Ott, S.J. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693 (2004).
25. Tsuda, M. et al. Prior stimulation of antigen-presenting cells with Lactobacillus regulates excessive antigen-specific cytokine responses in vitro when compared with Bacteroides. Cytotechnology 55, 89-101 (2007).
26. Yanagibashi, T, Hosono, A, Oyama, A, Tsuda, M, Hachimura, S &Takahashi, Y et al. Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer's patches. Biosci. Biotechnol. Biochem. 73, 372-377 (2009).
27. Yanagibashi, T. et al. IgA production in the large intestine is modulated by a different mechanism than in the small intestine: Bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA+ B cells. Immunobiology 218, 645-651 (2013).
28. Spor, A., Koren, O. &Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279-290 (2011).
29. Turnbaugh, P.J., Backhed, F., Fulton, L. &Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 3, 213-223 (2008).
30. Murphy, E.F. et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59, 1635-1642 (2010).
31. Fleissner, C.K., Huebel, N., Abd El-Bary, M.M., Loh, G., Klaus, S. &Blaut, M. Absence of intestinal microbiota does not protect mice from dietinduced obesity. Br. J. Nutr. 104, 919-929 (2010).
32. Gauffin Cano, P., Santacruz, A.,Moya, A. &Sanz, Y. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction inmice with high-fat-diet induced obesity. PLoS One 7, e41079 (2012).
33. Cooney, R. et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med 16, 90-97 (2010).
34. Homer, C.R., Richmond, A.L., Rebert, N.A., Achkar, J.P. &McDonald, C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139, 1630-1641 (2010).
35. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
36. Tilg, H. &Kaser, A. Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121, 2126-2132 (2011).
37. Lefebvre, P., Chinetti, G., Fruchart, J.C. &Staels, B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 116, 571-580 (2006).
38. Fu, J. et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 90-93 (2003).
39. Tsuchida, A. et al. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 54, 3358-3370 (2005).
40. Kim, B.H et al. Phenotype of peroxisome proliferator-activated receptoralpha( PPARalpha)deficient mice on mixed background fed high fat diet. J. Vet. Sci. 4, 239-244 (2003).
41. Ribet, C. et al. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes. Endocrinology 151, 123-133 (2010).
42. Ridlon, J.M., Kang, D.J. &Hylemon, P.B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241-259 (2006).
43. Sayin, S.I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225-235 (2013).
44. Tsuboyama-Kasaoka, N. et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147, 3276-3284 (2006).
45. Lim, Y.W. et al. Assessment of soil fungal communities using pyrosequencing. J. Microbiol. 48, 284-289 (2010).
46. Mishima, E. et al. Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-Induced CKD. J. Am. Soc. Nephrol. 26, 1787-1794 (2015).
47. Sugimoto, M, Wong, DT, Hirayama, A, Soga, T. &Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6, 78-95 (2010).
48. Sannasiddappa, T.H., Costabile, A., Gibson, G.R. &Clarke, S.R. The influence of Staphylococcus aureus on gut microbial ecology in an in vitro continuous culture human colonic model system. PLoS One 6, e23227 (2011).
49. Waget, A. et al. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 152, 3018-3029 (2011).